Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.37 |
| ▸ | GBA1 | P04062 | 3/20 | 0.37 |
| ▸ | GANAB | Q14697 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15072039 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL15623379 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL11083697 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL14410884 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL19782035 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL23988570 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL13082871 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL17779781 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL21095378 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 | |
| SCHEMBL19782036 | 1.00 | THRB (0.38) | THRBLMNASPHK2SPHK1GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230098432-A1 | SYNTHESIS OF GLYCOSYL FLUORIDES | CARBOCODE S A (PT) | 2023-03-30 | — | — | US | disclosed |
| US-20230094369-A1 | SYNTHESIS OF GLYCOSYLATED SPHINGOID BASES OF INTEREST OR ANALOGUES THEREOF | CARBOCODE S A (PT) | 2023-03-30 | — | — | US | disclosed |
| US-11540539-B2 | Reduced sodium food products | GENERAL MILLS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3054958-B1 | NEW PRADIMICIN DERIVATIVES FOR THE TREATMENT OF DISEASES CAUSED BY KINETOPLASTIDS | UNIV LEUVEN KATH (BE) | 2020-06-03 | — | — | EP | disclosed |
| US-20170172920-A1 | LIPOSOMES WITH GINSENOSIDE AS MEMBRANE MATERIAL AND PREPARATIONS AND USE THEREOF | Xiamen Ginposome Pharmaceutical Co., Ltd. (CN) | 2017-06-22 | — | — | US | disclosed |
| US-20160279248-A1 | EXTRACELLULAR TARGETED DRUG CONJUGATES | CENTROSE, LLC | 2016-09-29 | — | — | US | disclosed |
| US-9364554-B2 | Extracellular targeted drug conjugates | CENTROSE LLC (US) | 2016-06-14 | — | — | US | disclosed |
| US-20160045418-A1 | HAIR CARE SHAMPOO | HENKEL AG & CO. KGAA (DE) | 2016-02-18 | — | — | US | disclosed |
| WO-2015143185-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | AMYDIS DIAGNOSTICS (US) | 2015-09-24 | — | — | WO | disclosed |
| US-20140128309-A1 | CONDITIONING COSMETIC CLEANING AGENT HAVING IMPROVED FOAMING PROPERTIES | HENKEL AG & CO. KGAA (DE) | 2014-05-08 | — | — | US | disclosed |
| US-8470980-B2 | Extracellular targeted drug conjugates | CENTROSE, LLC (US) | 2013-06-25 | — | — | US | disclosed |
| US-20110064752-A1 | EXTRACELLULAR TARGETED DRUG CONJUGATES | CENTROSE, LLC (US) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110064752-A1 | EXTRACELLULAR TARGETED DRUG CONJUGATES | FCGR2A, ENGASE, FCER2 | THRB 1602/4885LMNA 1783/4885SPHK2 3589/4885 |
| US-20230098432-A1 | SYNTHESIS OF GLYCOSYL FLUORIDES | MAN2B1, GBA1, FUCA1 | THRB 752/4885LMNA 2492/4885SPHK2 1397/4885 |
| US-20160045418-A1 | HAIR CARE SHAMPOO | CD44, CUTA, ALG1 | THRB 3196/4885LMNA 1684/4885SPHK2 422/4885 |
| US-20170172920-A1 | LIPOSOMES WITH GINSENOSIDE AS MEMBRANE MATERIAL AND PREPARATIONS AND USE THEREOF | SGMS1, LIPA, SGMS2 | THRB 4857/4885LMNA 320/4885SPHK2 350/4885 |
| US-20160279248-A1 | EXTRACELLULAR TARGETED DRUG CONJUGATES | FCGR2A, ENGASE, FCER2 | THRB 1602/4885LMNA 1783/4885SPHK2 3589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.